FindTrial
Sign In

Transcriptional factor FOXK1 regulates invasion and metastasis in gastric cancer cells through CTGF and KLF2: a historical and prospective cohort study based on tissue samples

MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer: a historical and prospective cohort study based on tissue samples

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027330
Enrollment
Unknown
Registered
2019-11-09
Start date
2019-11-20
Completion date
Unknown
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

Case Series:N/A

Sponsors

Nanfang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with gastric cancer (including all pathological types of gastric cancer) diagnosed by the Department of Pathology of Nanfang Hospital, and surgically treated in Southern Hospital.

Exclusion criteria

Exclusion criteria: Patients who underwent preoperative chemotherapy.

Design outcomes

Primary

MeasureTime frame
The expression level of miR-646;—

Secondary

MeasureTime frame
The expression level of FOXK1;—

Countries

China

Contacts

Public ContactJide Wang

Nanfang Hospital, Southern Medical University

jidewang55@163.com+86 15217332212

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026